Lessons from the COVID-19 Pandemic: Knowledge and Preventive Actions Among a Mexican Population Sample

Lecciones de la pandemia de COVID-19: conocimiento y acciones preventivas de una muestra de población mexicana

Publicado 2021-01-03


https://doi.org/10.30554/archmed.21.1.3965.2021
##galleys.btn##
PDF (Inglês) FLIP HTML (Inglês) EPUB (Inglês) PDF (marcado) (Inglês) FLIP EPUB (marcado) (Inglês) XML (marcado) (Inglês)
Edição
v. 21 n. 1 (2021): .
Seção
Artículos de COVID 19
Como Citar
Konstat Korzenny, E. ., Morgenstern Kaplan, D. ., Fonseca Portilla, R. ., & Cohen Welch, A. . (2021). Lessons from the COVID-19 Pandemic: Knowledge and Preventive Actions Among a Mexican Population Sample: Lecciones de la pandemia de COVID-19: conocimiento y acciones preventivas de una muestra de población mexicana. Archivos De Medicina , 21(1), 247-256. https://doi.org/10.30554/archmed.21.1.3965.2021
Baixar Citação
Endnote/Zotero/Mendeley (RIS) BibTeX
DOI

https://doi.org/10.30554/archmed.21.1.3965.2021
Dimensions
PlumX

Como Citar

Konstat Korzenny, E. ., Morgenstern Kaplan, D. ., Fonseca Portilla, R. ., & Cohen Welch, A. . (2021). Lessons from the COVID-19 Pandemic: Knowledge and Preventive Actions Among a Mexican Population Sample: Lecciones de la pandemia de COVID-19: conocimiento y acciones preventivas de una muestra de población mexicana. Archivos De Medicina , 21(1), 247-256. https://doi.org/10.30554/archmed.21.1.3965.2021

Baixar Citação

##articleSummary.license##
Creative Commons License

Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Enrique Konstat Korzenny
Universidad Anáhuac México
https://orcid.org/0000-0002-1297-3112 ORCID
Dan Morgenstern Kaplan
Universidad Anáhuac México
https://orcid.org/0000-0002-9031-2256 ORCID
Rodrigo Fonseca Portilla
Universidad Anáhuac México
https://orcid.org/0000-0001-7130-0340 ORCID
Ariel Cohen Welch
Universidad Anáhuac México
https://orcid.org/0000-0002-9526-3596 ORCID
##submission.authorBio##

Enrique Konstat Korzenny,

Medical doctor. Facultad de Ciencias de la Salud, Universidad Anáhuac México, México City, México. 

Dan Morgenstern Kaplan,

Medical doctor. Facultad de Ciencias de la Salud, Universidad Anáhuac México, México City, México. 

Rodrigo Fonseca Portilla,

Medical doctor. Facultad de Ciencias de la Salud, Universidad Anáhuac México, México City, México

Ariel Cohen Welch,

Medical doctor. Facultad de Ciencias de la Salud, Universidad Anáhuac México, México City, México. 

Objectives: To evaluate the knowledge of the general population about the COVID-19 pandemic, including the disease and the preventive measures to reduce spreading of the virus undertaken by participants.

Methods: We conducted a cross-sectional study on a Mexican population sample during the period of March 20th to March 27th in Mexico, via a computer-based survey. We evaluated general knowledge about COVID-19 and the adherence to recommendations.

Results: A total of 2,577 participants completed the survey. Our results revealed an overall proper knowledge about the disease, with 76.2% having the proper knowledge about the disease, which was significantly correlated with age (r=0.15, p<0.001), socioeconomic status (r=0.06, p<0.003) and maximum academic level achieved by the study subjects (r=0.12, p<0.001).

Conclusions: Overall, people have good knowledge of COVID-19 and know about the specific public health recommendations, but a large proportion of people do not strictly follow these recommendations.

Visão geral 492 | Visualizações de PDF 25

Downloads

Os dados de download ainda não estão disponíveis.
  1. Tyrrell DA, Bynoe ML. Cultivation of viruses from a high proportion of patients with colds. Lancet. 1966; 1(7428):76–77. DOI: 10.1016/s0140-6736(66)92364-6
  2. Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Heal. 2020; 25(3):278–280. DOI: 10.1111/tmi.13383
  3. Schoeman D, Fielding BC. Coronavirus envelope protein: Current knowledge. Virol J. 2019; 16(1):1–22. . https://doi.org/10.1186/s12985-019-1182-0
  4. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
  5. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579(7798):270–273. http://dx.doi.org/10.1038/s41586-020-2012-7
  6. Battegay M, Kuehl R, Tschudin-Sutter S, Hirsch HH, Widmer AF, Neher RA. 2019-novel Coronavirus (2019-nCoV): estimating the case fatality rate - a word of caution. Swiss Med Wkly. 2020; 150:1-3. DOI: 10.4414/smw.2020.20203
  7. Zhang T, Wu Q, Zhang Z. Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak. Curr Biol. 2020; 30(7) 1346–1351. https://doi.org/10.1016/j.cub.2020.03.022
  8. Yuen KS, Ye ZW, Fung SY, Chan CP, Jin DY. SARS-CoV-2 and COVID-19: The most important research questions. Cell Biosci. 2020; 10(1):1–5. https://doi.org/10.1186/s13578-020-00404-4
  9. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 2020; 323(14):1406-1407. DOI: 10.1001/jama.2020.2565
  10. Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, et al. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from a Symptomatic Patient. JAMA. 2020; 323(16): 1610-1612. DOI: 10.1001/jama.2020.3227
  11. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-NCOV infection from an asymptomatic contact in Germany. N Engl J Med. 2020; 382(10):970–971. DOI: 10.1056/NEJMc2001468
  12. Anderson EL, Turnham P, Griffin JR, Clarke CC. Consideration of the Aerosol Transmission for COVID-19 and Public Health. Risk Anal. 2020; 40(5):902-907. DOI: 10.1111/risa.13500
  13. Klompas M, Baker MA, Rhee C. Airborne Transmission of SARS-CoV-2: Theoretical Considerations and Available Evidence. JAMA. 2020; 324(5):441-442. DOI:10.1001/jama.2020.12458
  14. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020; 382:1787–1799. DOI: 10.1056/NEJMoa2001282
  15. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3):269–271. https://doi.org/10.1038/s41422-020-0282-0
  16. Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther. 2020; 14(1):58–60. DOI: 10.5582/ddt.2020.01012
  17. Colson P, Rolain JM, Raoult D. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents. 2020; 55(3):10–11. DOI: 10.1016/j.ijantimicag.2020.105923
  18. Baron SA, Devaux C, Colson P, Raoult D, Rolain JM. Teicoplanin: an alternative drug for the treatment of COVID-19? Int J Antimicrob Agents. 2020; 55(4): 1-2. https://doi.org/10.1016/j.ijantimicag.2020.105944
  19. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020; 56(1):1-2. https://doi.org/10.1016/j.ijantimicag.2020.105949
  20. Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020; 396(10249):467-478. DOI: 10.1016/S0140-6736(20)31604-4.
  21. Amanat F, Krammer F. SARS-CoV-2 Vaccines: Status Report. Immunity. 2020; 52(4):583-589. https://doi.org/10.1016/j.immuni.2020.03.007
  22. Comisión Nacional de los Salarios Mínimos (México), Secretaría de Trabajo y Previsión Social. Salarios Mínimos 2020. Ciudad de México: Comisión Nacional de los Salarios Mínimos (México), Secretaría de Trabajo y Previsión Social; 2020.
  23. Geldsetzer P. Knowledge and Perceptions of COVID-19 Among the General Public in the United States and the United Kingdom: A Cross-sectional Online Survey. Ann Intern Med. 2020; 173(3):157-160. DOI: 10.7326/M20-0912
  24. Modi PD, Nair G, Uppe A, Modi J, Tuppekar B, Gharpure AS, et al. COVID-19 Awareness Among Healthcare Students and Professionals in Mumbai Metropolitan Region: A Questionnaire-Based Survey. Cureus. 2020; 12(4).:1-18. DOI: 10.7759/cureus.7514
  25. Roy D, Tripathy S, Kar SK, Sharma N, Verma SK, Kaushal V. Study of knowledge, attitude, anxiety & perceived mental healthcare need in Indian population during COVID-19 pandemic. Asian J Psychiatr. 2020; 51:1-7. https://doi.org/10.1016/j.ajp.2020.102083
  26. Kebede Y, Yitayih Y, Birhanu Z, Mekonen S, Ambelu A. Knowledge, perceptions and preventive practices towards COVID-19 early in the outbreak among Jimma university medical center visitors, Southwest Ethiopia. PLoS One. 2020; 15(5):1-15. DOI: 10.1371/journal.pone.0233744
  27. Honarvar B, Lankarani KB, Kharmandar A, Shaygani M, Zahedroozgar M, Rahmanian-Haghighi MR, et al. Knowledge, attitudes, risk perceptions, and practices of adults toward COVID-19: a population and field-based study from Iran. Int J Public Health. 2020; 65(6):731-739. DOI: 10.1007/s00038-020-01406-2
  28. Siddiqui AA, Alshammary F, Amin J, Rathore HA, Hassan I, Ilyas M, et al. Knowledge and practice regarding prevention of COVID-19 among the Saudi Arabian population.

Informações

Palavras-chave

Código QR

Sistema OJS 3.4.0.10 - Metabiblioteca |